A 60-year-old man had his aortic valve replaced and a HeartMate II ventricular assist device (VAD) inserted; 18 months later, he received a heart transplant. The explanted heart had a grossly fibrotic appearance on the ventricular side, with scar tissue extending onto the cusps. VAD therapy can lead to both acute and chronic changes in the valves, which may be clinically significant.
A 60-year-old man with known severe aortic stenosis presented with dyspnea. He had had multiple recent hospitalizations for systolic (low output) heart failure exacerbations. After several days of critical care support, he underwent aortic valve replacement with a 23-mm Carpentier-Edwards valve and implantation of a HeartMate II ventricular assist device (VAD). Due to the severity of systolic dysfunction, the chances of ventricular performance recovery with valve correction alone were thought to be poor, and the VAD was inserted at the time of valve replacement.
After 18 months of mechanical circulatory support, the patient went on to receive a heart transplant. Th e aortic valve bioprosthesis of the explanted heart had minimal changes on the aortic side but a grossly fi brotic appearance on the ventricular side. Th ere was scar tissue extending onto the cusps (Figure) .
DISCUSSION
With the prevalence of VAD therapy consistently increasing, the phenomenon of heart valve alterations in this setting is being recognized. Both acute and chronic changes have been noted in bioprosthetic as well as native valves in the setting of VAD therapy (1, 2) . Gross examination of explanted bioprostheses in the aortic valve position has disclosed endocardial fi brosis of the sewing rings and fi brous tissue extending onto the cusps with signifi cant fusion (1) . Histological examination of the aortic bioprosthesis after several weeks of VAD therapy revealed recent thrombus on the aortic surface and aggregates of macrophages on both surfaces of the cusps (1). Th e structural remodeling of the left ventricular outfl ow tract during VAD therapy is related, in large part, to mechanical stress on the tissue leading to infl ammation, deterioration, and fi brosis (3). Th is process could be clinically signifi cant as a potential source of emboli or as nidus for infection. Additionally, in the setting of bridge-to-recovery therapy, left ventricular outfl ow obstruction could limit parallel fl ow and elevate left ventricular end diastolic pressures, thereby limiting myocardial recovery (2) .
